Clinical research is at the heart of all medical advances and contributes greatly to improving the quality of medicine that is available to you and your loved ones. Participants in research studies—people just like you—are a critical link in making these discoveries possible.
Information about current study opportunities currently enrolling patients can be found below. Both ARC patients and non-ARC patients who fit trial eligibility requirements are welcome.
Enrolling studies
- Abbvie 3110-305-002 Pediatric Migraine Clinical Study: A phase III, multicenter, randomized, double-blind, placebo-controlled, single-attack study to evaluate the efficacy, safety, tolerability, and pharmacokinetics of oral Ubrogepant in the acute treatment of migraine with or without aura in children and adolescents (ages 6-17).
- Sanofi PSK05 Clinical Study: A phase III, randomized, modified double-blind, active-controlled, parallel-group, two-arm study to investigate the safety of a four-dose regimen of a 21-valent pneumococcal conjugate vaccine in healthy infants and toddlers.
- All enrolling studies.
Learn more by calling ARC Clinical Research at 737-247-7240 or visit ARCclinicalresearch.com.